Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lu-Hua Gao"'
Autor:
Huijie Bian, Zhao-Hui Zheng, Ding Wei, Aidong Wen, Zheng Zhang, Jian-Qi Lian, Wen-Zhen Kang, Chun-Qiu Hao, Jing Wang, Rong-Hua Xie, Ke Dong, Jie-Lai Xia, Jin-Lin Miao, Wen Kang, Guoquan Li, Di Zhang, Mingru Zhang, Xiu-Xuan Sun, Likun Ding, Kui Zhang, Junfeng Jia, Jin Ding, Zhiqin Li, Yanyan Jia, Lin-Na Liu, Zhe Zhang, Zhao-Wei Gao, Hong Du, Na Yao, Qing Wang, Ke Wang, Jie-Jie Geng, Bin Wang, Ting Guo, Ruo Chen, Yu-Meng Zhu, Li-Juan Wang, Qian He, Rui-Rui Yao, Ying Shi, Xiang-Min Yang, Jian-Sheng Zhou, Yi-Nan Ma, Ya-Tao Wang, Xue Liang, Fei Huo, Zhe Wang, Yang Zhang, Xu Yang, Ye Zhang, Lu-Hua Gao, Ling Wang, Xiao-Chun Chen, Hao Tang, Shuang-Shuang Liu, Qing-Yi Wang, Zhi-Nan Chen, Ping Zhu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-11 (2021)
Abstracts Recent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SARS-CoV-2 replication. Meplazumab
Externí odkaz:
https://doaj.org/article/5eed9c4f8a264dcb9b830636e8b40c7c
Autor:
Zhaohui Zheng, Wen Kang, Mingru Zhang, Ya-Tao Wang, Kui Zhang, Jin Ding, Likun Ding, Yanyan Jia, Ye Zhang, Xiang-Min Yang, Aidong Wen, Ding Wei, Bin Wang, Li-Juan Wang, Lin-Na Liu, Yu-Meng Zhu, Xue Liang, Yi-Nan Ma, Hao Tang, Guoquan Li, Jing Wang, Jie-Lai Xia, Yang Zhang, Hong Du, Zhe Zhang, Xiu-Xuan Sun, Rong-Hua Xie, Jie-Jie Geng, Ke Wang, Ling Wang, Na Yao, Xiao-Chun Chen, Ke Dong, Qing-Yi Wang, Shuang-Shuang Liu, Ping Zhu, Jian-Qi Lian, Junfeng Jia, Qian He, Zhe Wang, Rui-Rui Yao, Zhi-Nan Chen, Ting Guo, Huijie Bian, Chun-Qiu Hao, Jinlin Miao, Wen-Zhen Kang, Di Zhang, Lu-Hua Gao, Xu Yang, Zhao-Wei Gao, Fei Huo, Zheng Zhang, Ruo Chen, Qing Wang, Jian-Sheng Zhou, Ying Shi, Zhiqin Li
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-11 (2021)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
sRecent evidence suggests that CD147 serves as a novel receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Blocking CD147 via anti-CD147 antibody could suppress the in vitro SARS-CoV-2 replication. Meplazumab is a hum
Drug-Drug Interactions of Newly Approved Direct-Acting Antiviral Agents in Patients with Hepatitis C
Publikováno v:
International Journal of General Medicine
Hepatitis C is a major health problem worldwide, frequently resulting in cirrhosis and increasing the risk of hepatocellular carcinoma significantly. In recent years, the advent of direct-acting antivirals (DAAs) has dramatically improved the therape
Autor:
Yuan-Yuan Wang, Xin-Dong Luo, Xiao-Feng Huang, Ya-Fei Zhang, Qing-He Nie, Yong-Qian Cheng, Lu-Hua Gao, Jun-Qing Wang
Publikováno v:
Journal of Medical Virology. 84:1586-1592
Hepatitis C virus (HCV) infection in the uterus is a significant path of vertical HCV transmission. Some studies consider vertical HCV transmission in the uterus as the result of maternal blood leakage into infant blood, whereas others theorize that